Tag: ZEMDRI
Cipla becomes first to launch AMR drug ‘ZEMDRI’ in India
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy in complicated Urinary Tract infections (cUTI)
Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI
Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................